HomeBOLT • NASDAQ
Follow
Bolt Biotherapeutics Inc
Previous close
$1.22
Day range
$1.22 - $1.47
Year range
$0.84 - $2.03
Market cap
53.38M USD
Avg Volume
142.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 2.53M | 19.70% |
Operating expense | 5.76M | 5.01% |
Net income | -16.26M | 25.29% |
Net profit margin | -643.08 | 37.58% |
Earnings per share | -0.43 | 25.86% |
EBITDA | -17.72M | 19.11% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 119.72M | -30.04% |
Total assets | 175.36M | -28.57% |
Total liabilities | 47.10M | -17.46% |
Total equity | 128.26M | — |
Shares outstanding | 37.97M | — |
Price to book | 0.36 | — |
Return on assets | -24.84% | — |
Return on capital | -29.07% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -16.26M | 25.29% |
Cash from operations | -16.75M | -24.52% |
Cash from investing | 12.66M | 772.97% |
Cash from financing | 0.00 | — |
Net change in cash | -4.09M | 65.91% |
Free cash flow | -8.64M | -55.05% |
About
Founded
2015
Headquarters
Website
Employees
100